A meta-analysis of evidences on XPC polymorphisms and lung cancer susceptibility

Tumor Biology

Volumn 34, Issue 2, 2013, Pages 1205-1213

  Liu, Chuan ^a   Yin, Qinghua ^b   Hu, Jianbing ^b   Li, Lian ^c   Zhang, Yingyi ^a   Wang, Yajie ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b First People's Hospital of Yueyang   (China)

^c Yueyang Second People's Hospital   (China)

Author keywords

Lung cancer; Meta analysis; Polymorphism; XPC

Indexed keywords

ADENINE; ALANINE; CYTOSINE; GLUTAMINE; LYSINE; VALINE; XERODERMA PIGMENTOSUM GROUP C PROTEIN; DNA BINDING PROTEIN; XPC PROTEIN, HUMAN;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; DOMINANT INHERITANCE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RECESSIVE INHERITANCE; RISK ASSESSMENT; SYSTEMATIC REVIEW; XPC GENE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; META ANALYSIS; RISK FACTOR;

CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS;

MLCS; MLOWN;

EID: 84877128271     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0663-9     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Toh CK, Gao F, Lim WT, Leong SS, Fong KW, Yap SP, et al. Neversmokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol. 2006;24:2245-51.
3. Thoma BS, Vasquez KM. Critical DNA damage recognition functions of XPC-hHR23B and XPA-RPA in nucleotide excision repair. Mol Carcinog. 2003;38:1-13.
4. Tapias A, Auriol J, Forget D, Enzlin JH, Schärer OD, Coin F, et al. Ordered conformational changes in damaged DNA induced by nucleotide excision repair factors. J Biol Chem. 2004;279:19074-83.
5. Leibeling D, Laspe P, Emmert S. Nucleotide excision repair and cancer. J Mol Histol. 2006;37:225-38.
6. Khan SG, Metter EJ, Tarone RE, Bohr VA, Grossman L, Hedayati M, et al. A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism. Carcinogenesis. 2000;21:1821-5.
7. Khan SG, Muniz-Medina V, Shahlavi T, Baker CC, Inui H, Ueda T, et al. The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucleic Acids Res. 2002;30:3624-31.
8. Qiao Y, Spitz MR, Shen H, Guo Z, Shete S, Hedayati M, et al. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis. 2002;23:295-9.
9. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603-5.
10. Ades AE, Lu G, Higgins JP. The interpretation of random-effects meta-analysis in decision models. Med Decis Making. 2005;25:646-54.
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
12. Gordi T, Khamis H. Simple solution to a common statistical problem: interpreting multiple tests. Clin Ther. 2004;26:780-6.
13. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101-29.
14. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-58.
15. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315:629-34.
16. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-101.
17. Huang WY, Berndt SI, Kang D, Chatterjee N, Chanock SJ, Yeager M, et al. Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk. Cancer Epidemiol Biomarkers Prev. 2006;15:306-11.
18. Sakoda LC, Loomis MM, Doherty JA, Julianto L, Barnett MJ, Neuhouser ML, et al. Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers. Int J Mol Epidemiol Genet. 2012;3:1-17.
19. Chang JS, Wrensch MR, Hansen HM, Sison JD, Aldrich MC, Quesenberry Jr CP, et al. Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer. 2008;123:2095-104.
20. Raaschou-Nielsen O, Sørensen M, Overvad K, Tjønneland A, Vogel U. Polymorphisms in nucleotide excision repair genes, smoking and intake of fruit and vegetables in relation to lung cancer. Lung Cancer. 2008;59:171-9.
21. López-Cima MF, González-Arriaga P, García-Castro L, Pascual T, Marrón MG, Puente XS, et al. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer. 2007;7:162.
22. De Ruyck K, Szaumkessel M, De Rudder I, Dehoorne A, Vral A, Claes K, et al. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat Res. 2007;631:101-10.
23. Bai Y, Xu L, Yang X, Hu Z, Yuan J, Wang F, Shao M, et al. Sequence variations in DNA repair gene XPC is associated with lung cancer risk in a Chinese population: a case-control study. BMC Cancer. 2007;7:81.
24. Hu ZB, Wang YG, Ma HX, Tan W, Niu JY, Lin DX, et al. Association of two exonic genetic polymorphisms in the DNA repair gene XPC with risk of lung cancer in Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005; 22: 415-8.
25. Shen M, Berndt SI, Rothman N, Demarini DM, Mumford JL, He X, et al. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei China. Int J Cancer. 2005;116:768-73.
26. Vogel U, Overvad K, Wallin H, Tjønneland A, Nexø BA, Raaschou-Nielsen O. Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung cancer. Cancer Lett. 2005;222:67-74.
27. Lee GY, Jang JS, Lee SY, Jeon HS, Kim KM, Choi JE, et al. XPC polymorphisms and lung cancer risk. Int J Cancer. 2005;115:807-13.
28. Hu Z, Wang Y, Wang X, Liang G, Miao X, Xu Y, et al. DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population. Int J Cancer. 2005;115:478-83.
29. Marín MS, López-Cima MF, García-Castro L, Pascual T, Marrón MG, Tardón A. Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:1788-93.
30. Wang YG, Xing DY, Tan W, Wang LJ, Tang PZ, Lin DX. Poly(AT) polymorphism in DNA repair gene XPC and lung cancer risk. Zhonghua Zhong Liu Za Zhi. 2003; 25: 555-7
31. Minelli C, Thompson JR, Abrams KR, Thakkinstian A, Attia J. How should we use information about HWE in the meta-analyses of genetic association studies? Int J Epidemiol. 2008;37:136-46.
32. Manuguerra M, Saletta F, Karagas MR, et al. XRCC3 and XPD/ ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemiol. 2006;164:297-302.
33. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003;33:177-82.
34. Hecht SS. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res. 1999;424:127-42.